CLINICAL_TRIALS
trial_result
· 2022-12-29
Clinical Trial Update: Delineation of Sensorimotor Subtypes Underlying Residual Speech Errors [Phase 1]
Summary
Phase 1 clinical trial exploring sensorimotor subtypes underlying residual speech errors in Speech Sound Disorder; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: New York University | Conditions: Speech Sound Disorder | Phase 1 | Status: COMPLETED | Results posted: 2022-12-29